Table 1.
demographic characteristics of persons with positive SARS-CoV-2 PCR test by initial and persistent symptom status-Zambia, July 2020
| Overall N=302 | Initial symptoms*N=155 | Asymptomatic N=147 | Persistent symptoms N=27† | Resolved symptoms N=125† | ||||
|---|---|---|---|---|---|---|---|---|
| N (%) | N (%) | N (%) | P-Value | N (%) | N (%) | P-Value | ||
| Symptomatic | 155 (51.3) | |||||||
| Sex | Male | 128 (42.4) | 64 (41.3) | 64 (43.5) | 0.693¶ | 10 (37.0) | 53 (42.4) | 0.818¶ |
| Female | 174 (57.6) | 91 (58.7) | 83 (56.5) | 17 (63.0) | 72 (57.6) | |||
| Age group | 0-19 | 63 (21.0) | 35 (22.9) | 28 (19.0) | 0.718¶ | 6 (22.2) | 27 (22.0) | 0.692** |
| 20-49 | 195 (65.0) | 97 (63.4) | 98 (66.7) | 18 (66.7) | 79 (64.2) | |||
| 50+ | 42 (14.0) | 21 (13.7) | 21 (14.3) | 3 (11.1) | 17 (13.8) | |||
| Comorbidity‡ | 54 (17.9) | 21 (13.6) | 33 (22.4) | 0.044¶ | 3 (11.1) | 18 (14.4) | 0.672** | |
| HIV | 23 (8.1) | 9 (6.0) | 14 (10.3) | 0.188¶ | 2 (7.4) | 7 (5.9) | 0.716** | |
| Hypertension | 16 (5.3) | 6 (3.9) | 10 (6.8) | 0.309¶ | 0 (0.0) | 6 (4.8) | 0.407** |
*
Includes those that were experienced at time of diagnosis as well as those that developed after diagnosis; † three persons (one male, two females: 2 below the age of 20 years and one above 50 years), who indicated 'don't know' if they had persistent symptoms were excluded; ‡comorbid conditions included: hypertension, HIV, diabetes mellitus, asthma, chronic obstructive pulmonary disease and cancer; ¶ Pearson Chi-square test; ** Fisher's exact test; PCR: polymerase chain reaction